ADC Therapeutics SA
ADCT
$1.16
-$0.07-5.69%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.73M | -43.97M | -36.54M | -46.61M | -85.03M |
| Total Depreciation and Amortization | 793.00K | 802.00K | 838.00K | 843.00K | 847.00K |
| Total Amortization of Deferred Charges | -557.00K | 516.00K | 440.00K | 503.00K | 694.00K |
| Total Other Non-Cash Items | -1.39M | 9.07M | 7.24M | 11.09M | 45.06M |
| Change in Net Operating Assets | 10.03M | 8.54M | -4.82M | -9.92M | 6.80M |
| Cash from Operations | -21.85M | -25.04M | -32.85M | -44.10M | -31.63M |
| Capital Expenditure | -90.00K | -216.00K | -30.00K | -531.00K | -327.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -90.00K | -216.00K | -30.00K | -531.00K | -327.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 43.00K | -- | 98.70M | 356.00K | -- |
| Repurchase of Common Stock | -1.16M | -879.00K | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -1.12M | -879.00K | 98.70M | 356.00K | -1.00K |
| Foreign Exchange rate Adjustments | -343.00K | 291.00K | 12.00K | -43.00K | 152.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.41M | -25.85M | 65.83M | -44.31M | -31.81M |
